IV chemotherapy agents with high emetic risks⁠

🌟 Chemotherapy agents are notorious for causing many side effects such as nausea and vomiting and are classified according to their emetic risk. 🤢🤮⁠ ⁠ 🌟 High-risk agents cause emesis in more than 90% of patients and require pre-treatment with medications such as 5HT3 antagonists (ex: ondansetron), neurokinin-1 receptor antagonists (ex: aprepitant), and dexamethasone. ⁠ ⁠ 🧠 A fun way to learn which IV chemotherapy agents have high emetic risk – think of this story: ⁠ ⁠ ‘The car had motion sickness and threw up, making splat sounds”⁠ ⁠ 🤔 Can you imagine it in your head? This story will help you remember the medications DACARbazine, Mechlorethamine, Streptozotocin, and ciSPLATin. ⁠ ⁠ 🌟 Other IV chemotherapy agents that have high emetic risk at higher doses or in combination with other medications include:⁠ ⁠ -Carboplatin AUC>4⁠ -Carmustine >250 mg/m2⁠ -Cyclophosphamide >1500 mg/m3⁠ -Doxorubicin >60 mg/m2⁠ -Epirubicin >90 mg/m2⁠ -Ifosfamide >2 g/m2/dose⁠ -AC (any combo that contains an anthracycline + cyclophosphamide)